Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action

OBJECTIVE: Seventy percent of postmenopausal women experience vasomotor symptoms, which can be highly disruptive and persist for years. Hormone therapy and other treatments have variable efficacy and/or side effects. Neurokinin B signaling increases in response to estrogen deficiency and has been im...

Descripción completa

Detalles Bibliográficos
Autores principales: Prague, Julia K., Roberts, Rachel E., Comninos, Alexander N., Clarke, Sophie, Jayasena, Channa N., Mohideen, Pharis, Lin, Vivian H., Stern, Theresa P., Panay, Nicholas, Hunter, Myra S., Webber, Lorraine C., Dhillo, Waljit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092106/
https://www.ncbi.nlm.nih.gov/pubmed/29533369
http://dx.doi.org/10.1097/GME.0000000000001090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092106/
https://www.ncbi.nlm.nih.gov/pubmed/29533369
http://dx.doi.org/10.1097/GME.0000000000001090

Ejemplares similares